Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Efficacy, Long-Term Safety, and Tolerability of Ziprasidone in Children and Adolescents with Bipolar Disorder
Robert L. Findling, Idil Çavuş, Elizabeth Pappadopulos, et al.
Journal of Child and Adolescent Psychopharmacology (2013) Vol. 23, Iss. 8, pp. 545-557
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder
Lakshmi N. Yatham, Sidney H. Kennedy, Sagar V. Parikh, et al.
Bipolar Disorders (2018) Vol. 20, Iss. 2, pp. 97-170
Open Access | Times Cited: 1390
Safety of 80 antidepressants, antipsychotics, anti‐attention‐deficit/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic meta‐review of 78 adverse effects
Marco Solmi, Michele Fornaro, Edoardo G. Ostinelli, et al.
World Psychiatry (2020) Vol. 19, Iss. 2, pp. 214-232
Open Access | Times Cited: 234
QTc Interval Prolongation and Torsade de Pointes Associated with Second-Generation Antipsychotics and Antidepressants: A Comprehensive Review
Mehrul Hasnain, W. Victor R. Vieweg
CNS Drugs (2014) Vol. 28, Iss. 10, pp. 887-920
Closed Access | Times Cited: 141
A Systematic Review and Network Meta-Analysis to Assess the Relative Efficacy of Antipsychotics for the Treatment of Positive and Negative Symptoms in Early-Onset Schizophrenia
Rebecca Harvey, Anthony James, Gemma Shields
CNS Drugs (2016) Vol. 30, Iss. 1, pp. 27-39
Closed Access | Times Cited: 98
Aripiprazole for the treatment of pediatric bipolar I disorder: a 30‐week, randomized, placebo‐controlled study
Robert L. Findling, Christoph U. Correll, Margaretta Nyilas, et al.
Bipolar Disorders (2013) Vol. 15, Iss. 2, pp. 138-149
Closed Access | Times Cited: 72
Corrected QT Changes During Antipsychotic Treatment of Children and Adolescents: A Systematic Review and Meta-Analysis of Clinical Trials
Karsten Gjessing Jensen, Klaus Juul, Anders Fink‐Jensen, et al.
Journal of the American Academy of Child & Adolescent Psychiatry (2014) Vol. 54, Iss. 1, pp. 25-36
Closed Access | Times Cited: 69
A Focused Review on the Treatment of Pediatric Patients with Atypical Antipsychotics
Esther S. Lee, Carol Vidal, Robert L. Findling
Journal of Child and Adolescent Psychopharmacology (2018) Vol. 28, Iss. 9, pp. 582-605
Closed Access | Times Cited: 62
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) recommendations for the management of patients with bipolar disorder with mixed presentations
Lakshmi N. Yatham, Trisha Chakrabarty, David J. Bond, et al.
Bipolar Disorders (2021) Vol. 23, Iss. 8, pp. 767-788
Open Access | Times Cited: 52
Unmet needs in paediatric psychopharmacology: Present scenario and future perspectives
Antonio M. Persico, Celso Arango, Jan K. Buitelaar, et al.
European Neuropsychopharmacology (2015) Vol. 25, Iss. 10, pp. 1513-1531
Closed Access | Times Cited: 60
Effects of atypical antipsychotic drugs on QT interval in patients with mental disorders
Wilbert S. Aronow, Tatyana Shamliyan
Annals of Translational Medicine (2018) Vol. 6, Iss. 8, pp. 147-147
Open Access | Times Cited: 49
Lithium for the Maintenance Treatment of Bipolar I Disorder: A Double-Blind, Placebo-Controlled Discontinuation Study
Robert L. Findling, Nora McNamara, Mani N. Pavuluri, et al.
Journal of the American Academy of Child & Adolescent Psychiatry (2018) Vol. 58, Iss. 2, pp. 287-296.e4
Open Access | Times Cited: 47
Systematic Review and Network Meta-Analysis: Efficacy and Safety of Antipsychotics vs Antiepileptics or Lithium for Acute Mania in Children and Adolescents
Giovanni Vita, Viktor B. Nöhles, Giovanni Ostuzzi, et al.
Journal of the American Academy of Child & Adolescent Psychiatry (2024)
Open Access | Times Cited: 5
Neuromotor Adverse Effects in 342 Youth During 12 Weeks of Naturalistic Treatment With 5 Second-Generation Antipsychotics
Maren Carbon, Sandeep Kapoor, Eva M. Sheridan, et al.
Journal of the American Academy of Child & Adolescent Psychiatry (2015) Vol. 54, Iss. 9, pp. 718-727.e3
Open Access | Times Cited: 37
Harms of Antipsychotics in Children and Young Adults: A Systematic Review Update
Jennifer Pillay, Khrista Boylan, Amanda S. Newton, et al.
The Canadian Journal of Psychiatry (2018) Vol. 63, Iss. 10, pp. 661-678
Open Access | Times Cited: 32
Psychopharmacology of Bipolar Disorders in Children and Adolescents
Ekaterina Stepanova, Robert L. Findling
Pediatric Clinics of North America (2017) Vol. 64, Iss. 6, pp. 1209-1222
Closed Access | Times Cited: 30
Update on the Pharmacological Treatment of Tics with Dopamine-Modulating Agents
Sabine Mogwitz, Judith Buse, Nicole Wolff, et al.
ACS Chemical Neuroscience (2018) Vol. 9, Iss. 4, pp. 651-672
Closed Access | Times Cited: 30
Long-term Safety of Asenapine in Pediatric Patients Diagnosed With Bipolar I Disorder: A 50-Week Open-Label, Flexible-Dose Trial
Robert L. Findling, Ronald L. Landbloom, Mary Mackle, et al.
Pediatric Drugs (2016) Vol. 18, Iss. 5, pp. 367-378
Open Access | Times Cited: 28
Cardiac safety of antipsychotic medications in pediatric and adolescent population: a systematic review and pathways for future research
Simone Gasparini, Sara Senese, Erica Scuma, et al.
European Journal of Pediatrics (2024) Vol. 184, Iss. 1
Closed Access | Times Cited: 2
Practitioner Review: Long‐term pharmacological treatment of pediatric bipolar disorder
Covadonga M. Díaz‐Caneja, Carmen Moreno, Cloe Llorente, et al.
Journal of Child Psychology and Psychiatry (2014) Vol. 55, Iss. 9, pp. 959-980
Closed Access | Times Cited: 23
Treatment of Early-Age Mania: Outcomes for Partial and Nonresponders to Initial Treatment
John T. Walkup, Karen Dineen Wagner, Leslie Miller, et al.
Journal of the American Academy of Child & Adolescent Psychiatry (2015) Vol. 54, Iss. 12, pp. 1008-1019
Closed Access | Times Cited: 23
Metabolic consequences of second-generation antipsychotics in youth: appropriate monitoring and clinical management
Sanjiv Kumra, Rebecca Krill
Adolescent Health Medicine and Therapeutics (2014), pp. 171-171
Open Access | Times Cited: 17
Safety considerations in the psychopharmacology of pediatric bipolar disorder
Amanda Sun, Steven R. Woods, Robert L. Findling, et al.
Expert Opinion on Drug Safety (2019) Vol. 18, Iss. 9, pp. 777-794
Closed Access | Times Cited: 17
Early intervention for bipolar disorder – Do current treatment guidelines provide recommendations for the early stages of the disorder?
Ming Fang Chia, Sue Cotton, Kate Filia, et al.
Journal of Affective Disorders (2019) Vol. 257, pp. 669-677
Open Access | Times Cited: 16
Mixed States in Early-Onset Bipolar Disorder
Kirti Saxena, Sherin Kurian, Johanna Saxena, et al.
Psychiatric Clinics of North America (2019) Vol. 43, Iss. 1, pp. 95-111
Closed Access | Times Cited: 14
Management of Adverse Effects of Second-generation Antipsychotics in Youth
Marie Raffin, Marianna Gianitelli, Angèle Consoli, et al.
Current Treatment Options in Psychiatry (2014) Vol. 1, Iss. 1, pp. 84-105
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top